Analystreport

Celldex Therapeutics, Inc. (NASDAQ: CLDX) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.

Celldex Therapeutics, Inc.  (CLDX) 
Last celldex therapeutics, inc. earnings: 11/12 08:01 am Check Earnings Report
US:NASDAQ Investor Relations: ir.celldex.com